Background The usefulness of serum cystatin C and serum b 2 -microglobulin (B2M) as markers of glomerular filtration rate (GFR) were compared in kidney donors before and after nephrectomy.
Introduction
The ability to detect early rejection of the grafted kidney is crucial for all transplant programmes. The decision to biopsy is taken using an increase in serum creatinine of 27 mmol/L as a critical value, assuming that a change of this magnitude is unlikely to be due to either analytical or biological variation. Multiple markers of changes in renal function should provide a better assessment of whether decline in renal function accompanying rejection is occurring. Serum cystatin C is said to become abnormal when the glomerular ¢ltration rate (GFR) falls below 88 mL/min/1.73 m 2 , 1 and serum creatinine is said to only become abnormal at a GFR of 75 mL/min/1.73 m 2 . Therefore measurement of serum cystatin C may be useful in the early biochemical assessment of rejection.
In this study we compared the usefulness of cystatin C measurement, creatinine, urea and b 2 -microglobulin (B2M). Serum cystatin C and B2M, unlike creatinine, are not a¡ected by body mass or gender, although values do increase in the elderly.
Materials and methods
Twenty-eight voluntary kidney donors, 15 women median age 46 years, range 23^55 years, mean (standard deviation, SD) weight 51.6 (10.2) kg, mean (SD) height 151.2 (8.2) cm, and 13 men median age 37 years, range 25^52 years, mean (SD) weight 60.7 (8.9) kg, mean (SD) height 165.9 (6.2) cm, were studied.
Blood samples were taken at a median of 7 days (range 1^56 days) before and 10 days (range 5^20 days) after nephrectomy. The Cockcroft and Gault formula 2 was used to calculate creatinine clearance r Serum cystatin C was measured by a particleenhanced turbimetric assay (Dako, Glostrup, Denmark) and serum B2M by an immunoturbimetric assay (Tina-quant; Roche Diagnostics, Germany). Serum creatinine was measured by the Ja¡e¨kinetic method and urea by a UV kinetic method. All analyses were carried out on an Hitachi 912 autoanalyzer (Roche Diagnostics).
Between-day assay coe¤cients of variation were: cystatin C, 12.0% at 1.19 mg/L and 3.9% at 5.70 mg/L; B2M,12.0% at2.5 mg/L;creatinine,4.0% at115 mmol/L and 2.0% at 530 mmol/L; urea, 6.4% at 7.3 mmol/ L and 5% at 15.5 mmol/ L. All specimens were stored at 7208C for up to 3 months and the pre-and postspecimens from the same patient were analysed at the same time.
The probability of the di¡erence between two results on the same patient being analytically signi¢cant at a level of P50.05 is 2.8 times the overall standard deviation of the test, which was calculated from the analytical and intra-individual variation. The ¢gures for intra-individual variation were taken from the literature, being 4.9%, 4 13.3% 4 and 5.9%, 5 
Results
The results of all individual pre-and postnephrectomy measurements, calculated GFR and percentage changes are shown in Fig. 1 . Calculated GFR fell from 86.2 mL/min/1.73 m 2 (median) to 60.3 mL/min/1.73 m 2 , a median change of 728.6%. Serum creatinine increased from 80 mmol/L to 119mmol/L, a change +40%; urea increased from 4.3 mmol/L to 5.7 mmol/ L, although in three of the 28 patients it actually decreased (median, +30.4%). Serum cystatin C increased from 1.23 mg/ L to 1.66 mg/L (+31.2%) and serum B2M increased from 2.22 mg/ L to 3.75 mg/L (+65.6%).
Serum creatinine increased above its critical analytical value of +18 mmol/L in 26/28 patients (92.9%), B2M in 24/28 patients (85.7%) and cystatin C in only 8/28 (28.6%). All three parameters were increased above their critical values in eight patients, and all three failed to rise in two patients who had a reduction in GFR of 11.1% and 12.5%. B2M and serum creatinine agreed in 24 patients.
However, the value used in our hospital for detecting the occurrence of renal transplant rejection is 27 mmol/L. Using this ¢gure, 23/28 (82.1%) of patients showed a signi¢cant increase in serum creatinine. Before nephrectomy, abnormal values of serum B2M and cystatin C were seen in three patients and ten patients, respectively, all with a normal serum creatinine. Serum creatinine was abnormal in only one person (male, 124 mmol/L) before nephrectomy.
Discussion
Although the initial loss of GFR after nephrectomy is around 50%, it is well established that the GFR increases in the remaining kidney to about 72% of the pre-operative value in a week, with a maximum increase to about 78%. 6 The decrease in estimated GFR in our patients 10 days after nephrectomy was 28.6%. None of the markers was 100% sensitive to detect this change. Serum cystatin C was least sensitive, re£ecting the large inter-individual biological variation. 4 Serum B2M showed the greatest increase. However, an increase in B2M is not speci¢c to a fall in GFR since it is elevated in viral infections, including HIV, re£ecting lymphocyte turnover. 7 Furthermore, it has been shown that serum B2M re£ects changes in lymphocyte activation in post-transplant patients. 8 Even though this test is available in our laboratory it has been ruled out for the detection of a reduction in GFR.
Oddoze et al. 9 reported that serum creatinine, B2M and cystatin C in diabetics with GFR less than 60 mL/ min were 50.5, 78.8 and 43.6% higher compared to diabetics with GFR greater than 80 mL/min.
In a recent review 10 it was concluded that cystatin C can o¡er advantages over creatinine as an index of GFR. In an analysis of 24 studies on the clinical utility of cystatin C, Laterza et al. 11 found that in 20 studies cystatin C was superior to serum creatinine in detecting impaired GFR. This has not been the ¢nding in this study. Cystatin C, due to large intra-individual variation, performed badly in detecting changes within a patient. This is consistent with the ¢ndings of Keevil et al., 4 who found that, in order to show a change cystatin C, values have to di¡er by at least 37% of the reference mean value, while the equivalent value for serum creatinine is only 14%. This study has found that serial measurements of either B2M or cystatin C do not o¡er any additional useful information in the detection of impaired renal function compared to the serial measurement of serum creatinine in patients before and after nephrectomy.
